CClinicalTrials.gg
CompletedNCT01731145SNUMAPUpdated Jul 8, 2015

Assessment of Tremor Using SNUMAP Motion Sensing System

An interventional study of SNUMAP in Tremor, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2015-07-08.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
187
Allocation
Non-randomized
Ages
20 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to record and measure tremor using portable six-axis (tri-axial accelerometer and tri-axial gyroscope) motion sensing system.

Read the detailed description

SNUMAP system is portable, finger-worn, battery powered device that contains MEMS (micro-electro-mechanical system) hybrid motion sensor (three-axis accelerometer and three-axis gyroscope). The SNUMAP device consists of a wrist module and finger module, which attaches to an patients's finger and transmits three dimensional motions to a wrist module for storage and further analysis. The aims of this study is to assess tremor severity using tri-axial accelerometry and gyroscope to determine the reliability and the correlation with clinical measurements.

02

Conditions studied

  • Tremor

Browse trials for

Keywords

  • Tremor
  • SNUMAP
  • accelerometry
  • gyroscope
  • clinical rating scale
03

In context

Tremor

257 studies on the registry are indexed under Tremor; 59 are open to participants now.

This study's enrollment of 187 is above the median of 25 across 184 interventional studies indexed under Tremor.

Browse Tremor studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age: 20-80 years
  • Patients with tremor (involuntary, rhythmic, oscillatory movement in one or more body part)
  • Subject who signed an informed consent

Exclusion criteria

Exclusion Criteria:

  • Pregnant or nursing woman.
  • Comorbid neurologic illnesses that impact the ability to perform the study tasks.
  • Subjects with medical condition that in the opinion of the investigator would affect his/her ability to participate in this study.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
187 participants (actual)

Study arms

  • Experimental
    SNUMAP assessment

    Uses SNUMAP motion sensing system to quantify tremor symptom.

    Device: SNUMAP

Interventions

  • DeviceSNUMAP

    Portable six-axis (tri-axial accelerometer and tri-axial gyroscope) motion sensing system

    Also known as: Hybrid (accelerometer and gyroscope)

06

What researchers measure

Primary outcomes

  1. 3-D Accelerometric and gyroscope variables measured

    Correlation between SNUMAP motion sensing system symptom assessment and clinical tremor rating scale (TRS) scores

    Time frame: 1 day

07

Study locations

1 site
  • Department of Neurology, Seoul National University Hospital
    Seoul, 110-744, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01731145
Lead sponsor
Seoul National University Hospital
Collaborators
Life Science Technology Inc.
Responsible party
BS Jeon (Professor and Chairman, Department of Neurology, Seoul National University Hospital) — Principal investigator
First posted
Nov 21, 2012
Start date
Aug 2014
Primary completion
Feb 2015
Completion
Feb 2015
Last update
Jul 8, 2015

Study contacts

Beom S Jeon, M.D., Ph.D.
principal investigator · Seoul National University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion